1-5 of 5
Christopher H. Keir
Close
Sort by
Journal Articles

False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy

Clinical Trials & Observations
Theodore W. Laetsch, Shannon L. Maude, Michael C. Milone, Kara L. Davis, Joerg Krueger, Ana Maria Cardenas, Lamis K. Eldjerou, Christopher H. Keir, Patricia A. Wood, Stephan A. Grupp
Journal: Blood
Blood (2018) 131 (23): 2596–2598.
https://doi.org/10.1182/blood-2017-12-822940
Published: 2018
Journal Articles

Successful Translation of Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Cell Processing Technology from Academia to Industry

Jeffrey A. Boyd, MBA, Bruce L. Levine, PhD, Kathrin Jinivizian, BS, Margit A. Jeschke, PhD, Megan M. Suhoski Davis, PhD, Zhaohui Zheng, MS, Daniel Stark, PhD, Liza Loidolt, MS, MBA, Christopher H. Keir, MD MS, Patricia A. Wood, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3100.
https://doi.org/10.1182/blood.V126.23.3100.3100
Published: 2015
Journal Articles

Comparison of Survival Rates, Healthcare Resource Use and Costs of Elderly Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As Second-Line Therapy

B. Douglas Smith, MD, Jun Liu, PhD, Dominick Latremouille-Viau, MSc, Zhou Zhou, MSc, Annie Guerin, MSc, Daniel Fernandez, MA, Dingdong Yi, BS, Xufei Wang, MA, Eric Q Wu, PhD, Shivani K Mhatre, MSc, Christopher H Keir, MD, Lei Chen, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2618.
https://doi.org/10.1182/blood.V124.21.2618.2618
Published: 2014
Journal Articles

A Retrospective Analysis of Treatment Patterns in Elderly Patients with Chronic Myeloid Leukemia Receiving Dasatinib or Nilotinib As Second-Line Therapy after Imatinib

B. Douglas Smith, MD, Jun Liu, PhD, Dominick Latremouille-Viau, MSc, Zhou Zhou, MSc, Annie Guerin, MSc, Daniel Fernandez, MA, Dingdong Yi, BS, Xufei Wang, MA, Eric Q Wu, PhD, Shivani K Mhatre, MSc, Christopher H Keir, MD, Lei Chen, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1293.
https://doi.org/10.1182/blood.V124.21.1293.1293
Published: 2014
Journal Articles

Deep Molecular Response in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated With Nilotinib: ENESTnext Update

Michael J. Mauro, MD, Shaker Dakhil, MD FACP, Jorge E. Cortes, MD, David A. Rizzieri, MD, Christopher H Keir, MD, Sandy Yi, MS, Michael C. Heinrich, MD, Stuart L. Goldberg, MD, Rosalind Catchatourian, MD, Philip Kuriakose, MD, Jerald P Radich, MD
Journal: Blood
Blood (2014) 124 (21): 1796.
https://doi.org/10.1182/blood.V124.21.1796.1796
Published: 2014